Artwork

Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

59:31
 
Share
 

Manage episode 481224917 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Featuring perspectives from Prof Rebecca A Dent and Dr Nancy U Lin, including the following topics:

  • Introduction: A New Paradigm for Triple-Positive Breast Cancer? (0:00)
  • CDK4/6 Inhibitors for HR-Positive, HER2-Negative Breast Cancer (10:06)
  • Oral Selective Estrogen Receptor Degraders for HR-Positive, HER2-Negative Breast Cancer (21:17)
  • Treatment of PIK3CA/PTEN/AKT-Mutated Breast Cancer (31:34)
  • Antibody-Drug Conjugates (ADCs) for HR-Positive, HER2-Negative Breast Cancer (38:41)
  • ADCs for HER2-Positive Breast Cancer (46:30)
  • HER2-Targeting Tyrosine Kinase Inhibitors for HER2-Positive Breast Cancer (53:26)
  • ADCs for Advanced Triple-Negative Breast Cancer (58:29)

CME information and select publications

  continue reading

1527 episodes

Artwork
iconShare
 
Manage episode 481224917 series 1464352
Content provided by Dr Neil Love. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr Neil Love or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Featuring perspectives from Prof Rebecca A Dent and Dr Nancy U Lin, including the following topics:

  • Introduction: A New Paradigm for Triple-Positive Breast Cancer? (0:00)
  • CDK4/6 Inhibitors for HR-Positive, HER2-Negative Breast Cancer (10:06)
  • Oral Selective Estrogen Receptor Degraders for HR-Positive, HER2-Negative Breast Cancer (21:17)
  • Treatment of PIK3CA/PTEN/AKT-Mutated Breast Cancer (31:34)
  • Antibody-Drug Conjugates (ADCs) for HR-Positive, HER2-Negative Breast Cancer (38:41)
  • ADCs for HER2-Positive Breast Cancer (46:30)
  • HER2-Targeting Tyrosine Kinase Inhibitors for HER2-Positive Breast Cancer (53:26)
  • ADCs for Advanced Triple-Negative Breast Cancer (58:29)

CME information and select publications

  continue reading

1527 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play